Image - Barts and The London logo and link to home page Image - divider Image - divider
 
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Cancer Prevention title and link to CCP homepage
 
Centre for Cancer Prevention publications 2003
Adams C, Cardwell C, Cook C, Edwards R, Atkin WS, Morton DG. Effect of hysterectomy status on polyp detection rates at screening flexible sigmoidoscopy. Gastrointest Endosc 2003;57:848-853. pISSN: 00165107.
The ATAC Trialists' Group (2003) (includes J Cuzick, Independent Statistician). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer - Results of the ATAC (arimidex, tamoxifen alone or in combination) trial efficacy and safety update analysis. Cancer , 98: 1802-1810.
Bala DV, Duffy SW, Patel DD, Shah PM, Charman SC, Prevost TC, Upponi S, Patel PS, Trivedi J, Patel P, Pandey P, Patel R, Rana P, Rao K, Warwick J. Breast cancer, reported dietary intakes and dietary biomarkers: a case-control study in Gujarat, India. Res Adv Cancer 2003;3:219-230.
Bjurstam N, Bjorneld L, Med LF, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom L-O, Lingaas H, Mattsson J, Persson S, Rudenstam C-M, Salander H, Save-Soderbergh J, Wahlin T. Age-specific effects of mammography screening: The randomized breast screening trial in Gothenburg. Am J Oncol Rev 2003;2:435-442. ISSN: 15429520.
Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E, Eriksson O, Hafstrom LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Save-Soderbergh J, Wahlin T. The Gothenburg Breast Screening Trial. Cancer 2003;97:2387-2396. pISSN: 0008543X.
Cuzick J. Human papilloma screening for lower genital tract neoplasia. In: Lower Genital Tract Neoplasia . Maclean A, Singer A & Critchley H (Eds). London, RCOG Press, 2003, 108-113. ISBN: 1900364816.
Cuzick J. Aromatase Inhibitors in Prevention: Data from the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial and the Design IBIS II (The second international Breast Cancer Intervention Study). In: Tumour Prevention and Genetics . Series: Recent Results in Cancer Research Vol 163. Senn H-J & Morant R (Eds). Berlin, London, Springer, 2003, 96-103. pISSN: 00800015, ISBN: 3 540440623.
Cuzick J. (Associate Editor). Evidence-based Oncology . Williams C (Ed). London, BMJ Books, 2003. ISBN: 0727914391.
Cuzick J. Breast cancer prevention trials. In: Evidence-based Oncology . Williams C (Ed). London, BMJ Books, 2003, 48-52. ISBN: 0727914391.
Cuzick J. Chemoprevention of breast cancer. Am J Oncol Rev 2003;2:319-321. pISSN: 15429520.
Cuzick J. Epidemiology of breast cancer - selected highlights. The Breast 2003;12:405-411. pISSN: 09609776.
Cuzick J. Vaccination against cervical cancer: trial boost hopes. Trends in Urology, Gynaecology and Sexual Health 2003;8:5-6. p ISSN: 13625306
Cuzick J. Book Review: Cancer Screening: a practical guide for physicians (edited by Aziz K, Wu GY). Clin Oncol 2003;15:33-34. pISSN: 03057399.
Cuzick J, Forbes J, Howell A (for the IBIS Investigators). Tamoxifen for breast-cancer prevention (authors' reply). Lancet 2003;361:178. pISSN: 01406736.
Cuzick J, O'Neill C, Howell T, Forbes J. Anastrozole for ductal carcinoma in situ. Lancet 2003;362:832-833. pISSN: 01406736.
Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P. Overview of the main outcomes in breast cancer prevention trials. Lancet 2003;361:296-300. pISSN: 01406736.
Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003). Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet , 362: 1871-1876.
Duffy SW. Commentary on Annual mammography and breast examination did not reduce breast cancer mortality in women aged 40-49 years (CNBSS-1). Evid Based Obstet Gynecol 2003;5:47. ISSN: 1361259X.
Duffy SW. Screening for breast cancer. In: Evidence-based Oncology . Williams C (Ed). London, BMJ Books, 2003, 109-117. ISBN: 0727914391.
Duffy SW, Rohan TE, Kandel R, Prevost TC, Rice K, Myles JP. Misclassification in a matched case-control study with variable matching ratio: application to a study of c-erbB-2 overexpression and breast cancer. Stat Med 2003;22:2459-2468. pISSN: 02776715.
Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HH, Yen MF. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003;39:1755-1760. pISSN: 09598049.
Duffy SW, Tabar L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol 2003;14:1196-1198. pISSN: 09237534.
Duggan C, Marriott K, Edwards R, Cuzick J. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol 2003;21:3588-3593. pISSN: 0732183X.
Forbes J, Cuzick J, Wilcken N. Breast cancer. In: Evidence-based Oncology . Williams C (Ed). London, BMJ Books, 2003, 429-464. ISBN: 0727914391.
Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A. Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol 2003;69:118-121. pISSN: 0146-6615.
Houghton J, Cuzick J, Baum M. Design and statistical considerations. In: History and Advancement of Anastrozole in the Treatment of Breast Cancer Buzlar A & Baum M (Eds). London, Royal Society of Medicine Press Ltd, 2003, 37-44. ISBN: 1853155578.
Jackson C, Sharples LD, Thompson SG, Duffy SW, Couto E, Scott RAP. Multi-state Markov models for disease progression with classification error. The Statistician 2003;52:193-209. pISSN: 00390526.
Kaufmann M, Jonat W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, Schumacher M, Saurbrei W on behalf of the Zoladex Early Breast Cancer Research Association (ZEBRA) Trialists' Group. Survival analyses from ZEBRA study: goserelin (Zoladex TM ) versus CMF in premenopausal women with node-positive breast cancer. Eur J Cancer 2003;39:1711-1717. pISSN: 09598049.
Liu WJ, Lee LT, Yen MF, Tung TH, Williams R, Duffy SW, Chen THH. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabet Med 2003;20:727-733. pISSN: 07423071.
McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African Caribbean and white British women in the UK. Br J Cancer 2003;88:42-46. pISSN: 00070920.
Myles JP, Nixon RM, Duffy SW, Tabar L, Boggis C, Evans G, Shenton A, Howell A. Bayesian evaluation of breast cancer screening using data from two studies. Stat Med 2003;22:1661-1674. pISSN: 02776715.
Myles JP, Price GM, Hunter N, Day M, Duffy SW. A potentially useful distribution model for dietary intake data. Public Health Nutr 2003;6:513-519. pISSN: 13689800.
Nixon RM, Duffy SW, Fender GR. Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint. BMC Med Res Methodol 2003;3:17. eISSN: 14712288.
Novelli M, Cossu A, Oukrif D, Quaglia A, Lakhani S, Poulsom R, Sasieni P, Carta P, Contini M, Pasca A, Palmieri G, Bodmer W, Tanda F, Wright N. X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci USA 2003;100:3311-3314. pISSN: 00278424.
Sasieni P. Cervical screening. In: Evidence-based Oncology . Williams C (Ed). London, BMJ Books, 2003, 118-132. ISBN: 0727914391.
Sasieni P. Epidemiology of lower genital tract neoplasia. In: Lower Genital Tract Neoplasia . MacLean AB, Singer A, Critchley H (Eds). London, RCOG Press, 2003, 3-16. ISBN: 1900364816.
Sasieni P. Evaluation of the UK breast screening programmes. Ann Oncol 2003;14:1206-1208. pISSN: 09237534.
Sasieni P. On the expected number of cancer deaths during follow-up of an initially cancer-free cohort. Epidemiology 2003;14:108-110. pISSN: 10443983.
Sasieni PD. Outcomes of screening to prevent cancer: think of screening as insurance. Author's reply. BMJ 2003;327:50. pSSN: 09598138.
Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93. pISSN: 00070920.
Sasieni P, Cuzick J. Epidemiology of gynaecological cancer. In: Gynaecology, 3 rd edition . Shaw RW, Soutter WP, Stanton SL (Eds). London, Churchill Livingstone, 2003, 513-526. ISBN: 0443070296.
Sasieni P, Cuzick J. The UK breast-screening programme should start at age 47 years. Lancet 2003;362:246-247. pISSN: 01406736.
Szarewski A. The combined contraceptive pill. Practitioner 2003;247:458, 461-466, 468-469. pISSN: 0032-6518.
Tabar L, Duffy SW, Smith RA. Mammography service screening and mortality. Authors' reply. Lancet 2003;362:330. pISSN: 01406736.
Tabar L, Smith RA, Vitak B, Yen MF, Chen TH, Warwick J, Myles JP, Duffy SW. Mammographic screening: a key factor in the control of breast cancer. Cancer J 2003;9:15-27. pISSN: 15289117.
Tabar L, Yen M-F, Vitak B, Chen H-HT, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405-1410. pISSN: 01406736.
UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma in situ (DCIS) Working Party on behalf of DCIS trialists in the UK, Australia, and New Zealand (Cuzick J as member). Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003;362:95-105. pSSN: 01406736.
Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus (HPV) among women attending a well-woman clinic. Sex Transm Infect 2003;79:320-322. pISSN: 1368-4973.
Wardle J, Williamson S, McCaffrey K, Sutton S, Taylor T, Edwards R, Atkin W. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol 2003;22:99-105. pISSN: 02786133.
Wardle J, Williamson S, Sutton S, Biran A, McCaffery K, Cuzick J, Atkin W. Psychological impact of colorectal cancer screening. Health Psychol 2003;22:54-59. pISSN: 02786133.
Warren RML, Young JR, McLean L, Lyons K, Wilson RM, Evans A,Duffy SW, Warsi I. Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead time of radiological signs. Clin Radiol 2003;58:128-132. pISSN: 00099260.
Warwick J, Pinney E, Warren RML, Duffy SW, Howell A, Wilson M, Cuzick J. Breast density and breast cancer risk factors in a high-risk population. The Breast 2003;12:10-16. pISSN: 09609776.
Wilkinson C, Szarewski A. Contraceptive Dilemmas . St Albans, Herts, Altman, 2003. ISBN: 1860360246.
Winnett A, Sasieni P. Iterated residuals and time-varying covariate effects in Cox regression. J R Statist Soc B 2003;65:473-488. pISSN: 13697412.
Yen MF, Tabar L, Vitak B, Smith RA, Chen HH, Duffy SW. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003;39:1746-1754. pISSN: 09598049.
 
Top
 

Useful links:
  WIPM publications hub
    EPM
    CCP
    Psychiatry
    GPRF/EMCU

by CCP Website Manager © Queen Mary, University of London 2011
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850  Fax: 020 7882 3890